Ascendis Health (JSE:ASC) 3-Year Revenue Growth Rate : -17.80% (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health 3-Year Revenue Growth Rate?

Ascendis Health's Revenue per Share for the six months ended in Jun. 2023 was R1.21.

During the past 12 months, Ascendis Health's average Revenue per Share Growth Rate was -22.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -17.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -28.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Ascendis Health was 76.10% per year. The lowest was -35.60% per year. And the median was -11.10% per year.

Competitive Comparison of Ascendis Health's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Ascendis Health's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Health's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascendis Health's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ascendis Health's 3-Year Revenue Growth Rate falls into.

Ascendis Health 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Ascendis Health (JSE:ASC) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Ascendis Health 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ascendis Health's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.